CIK: 0001012622 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 15, 2016
Total Value ($000): $429,576 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ACCELERATE DIAGNOSTICS INC | 5,087,456 | $73,208 | 17.0% | $24998.12 | — | COM | 004304200 |
| — | NXSTAGE MEDICAL INC | 2,670,536 | $57,897 | 13.5% | $13115.35 | — | COM | 67072V103 |
| — | TESARO INC | 666,956 | $56,058 | 13.0% | $23880.15 | — | COM | 881569107 |
| — | MAZOR ROBOTICS LTD | 2,766,517 | $49,742 | 11.6% | $11234.47 | — | SPONSORED ADS | 57886P103 |
| — | QUIDEL CORP | 2,533,554 | $45,249 | 10.5% | $25530.00 | — | COM | 74838J101 |
| OPK | OPKO HEALTH INC | 3,914,000 | $36,557 | 8.5% | $6.96 | +45.9% | COM | 68375N103 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 3,182,269 | $22,387 | 5.2% | $4.10 | +122.7% | COM | 69404D108 |
| ARAY | ACCURAY INC | 2,482,718 | $12,885 | 3.0% | $5.71 | -4.2% | COM | 004397105 |
| — | BIOLASE INC | 10,529,525 | $12,320 | 2.9% | $1522.78 | — | COM | 090911108 |
| — | AMARIN CORP PLC | 5,691,572 | $12,294 | 2.9% | $947.16 | — | SPONS ADR NEW | 023111206 |
| — | HANSEN MEDICAL | 4,491,820 | $11,702 | 2.7% | $722.69 | — | COM | 411307101 |
| — | INTREXON CORP | 459,529 | $11,309 | 2.6% | $7613.52 | — | COM | 46122T102 |
| — | VERMILLION INC | 8,624,225 | $9,573 | 2.2% | $1646.88 | — | COM NEW | 92407M206 |
| — | AGENUS INC | 1,857,477 | $7,523 | 1.8% | $1053.96 | — | COM | 00847G101 |
| — | TRANSITION THERAPEUTICS INC | 3,817,972 | $5,612 | 1.3% | $3769.73 | — | COM NEW | 893716209 |
| — | CONTRAFECT CORP | 1,182,032 | $3,416 | 0.8% | $5.25 | — | COM | 212326102 |
| BIIB | BIOGEN INC | 6,723 | $1,625 | 0.4% | $213.68 | +23.3% | COM | 09062X103 |
| — | SECOND SIGHT MED PRODS INC | 50,804 | $182 | 0.0% | $10.26 | — | COM | 81362J100 |
| — | ZIOPHARM ONCOLOGY INC | 6,661 | $37 | 0.0% | $12.00 | — | COM | 98973P101 |